Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model

Malignant melanoma, an aggressive form of skin cancer, has a low five-year survival rate in patients with advanced disease. Immunotherapy represents a promising approach to improve survival rates among patients at advanced stage. Herein, the aim of the study was to design and produce, by using engin...

Descripción completa

Detalles Bibliográficos
Autores principales: Garofalo, Mariangela, Bertinato, Laura, Staniszewska, Monika, Wieczorek, Magdalena, Salmaso, Stefano, Schrom, Silke, Rinner, Beate, Pancer, Katarzyna Wanda, Kuryk, Lukasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070801/
https://www.ncbi.nlm.nih.gov/pubmed/33919827
http://dx.doi.org/10.3390/pharmaceutics13040547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070801/
https://www.ncbi.nlm.nih.gov/pubmed/33919827
http://dx.doi.org/10.3390/pharmaceutics13040547

Ejemplares similares